Real-time 2D separation by LC × differential ion mobility hyphenated to mass spectrometry by Varesio, Emmanuel et al.
ORIGINAL PAPER
Real-time 2D separation by LC × differential ion mobility
hyphenated to mass spectrometry
Emmanuel Varesio & J. C. Yves Le Blanc &
Gérard Hopfgartner
Received: 29 July 2011 /Revised: 21 September 2011 /Accepted: 23 September 2011 /Published online: 18 October 2011
# Springer-Verlag 2011
Abstract The liquid chromatography–mass spectrometry
(LC-MS) analysis of complex samples such as biological
fluid extracts is widespread when searching for new
biomarkers as in metabolomics. The success of this
hyphenation resides in the orthogonality of both separation
techniques. However, there are frequent cases where
compounds are co-eluting and the resolving power of mass
spectrometry (MS) is not sufficient (e.g., isobaric com-
pounds and interfering isotopic clusters). Different strate-
gies are discussed to solve these cases and a mixture of
eight compounds (i.e., bromazepam, chlorprothixene, clo-
napzepam, fendiline, flusilazol, oxfendazole, oxycodone,
and pamaquine) with identical nominal mass (i.e., m/z 316)
is taken to illustrate them. Among the different approaches,
high-resolution mass spectrometry or liquid chromatogra-
phy (i.e., UHPLC) can easily separate these compounds.
Another technique, mostly used with low resolving power
MS analyzers, is differential ion mobility spectrometry
(DMS), where analytes are gas-phase separated according
to their size-to-charge ratio. Detailed investigations of the
addition of different polar modifiers (i.e., methanol,
ethanol, and isopropanol) into the transport gas (nitrogen)
to enhance the peak capacity of the technique were carried
out. Finally, a complex urine sample fortified with 36
compounds of various chemical properties was analyzed by
real-time 2D separation LC×DMS-MS(/MS). The addition
of this orthogonal gas-phase separation technique in the
LC-MS(/MS) hyphenation greatly improved data quality by
resolving composite MS/MS spectra, which is mandatory in
metabolomics when performing database generation and
search.
Keywords Real-time 2D separation . Differential ion
mobility spectrometry . Liquid chromatography .Mass
spectrometry
Introduction
When complex mixtures of low molecular weight com-
pounds were analyzed, a high peak capacity is mandatory
to avoid the loss of relevant analyte information. Very
often, liquid chromatography (LC) or gas chromatography
(GC) is hyphenated to mass spectrometry (MS) to separate
the numerous constituents of such samples. If the separation
power is not sufficient, comprehensive two-dimensional
(2D) chromatography (e.g., GC×GC and LC×LC) can
increase the chromatographic peak capacity, but the second
dimension requires very fast separation speed that can be
challenging for LC. Holland and Jorgensen have demon-
strated that the LC cycle time of the second dimension
needs to be around one third of the first dimension peak
width in order to have an efficient and comprehensive
sampling [1]. Moreover, Giddings showed that the peak
capacity of both dimensions could be multiplied only when
both retention mechanisms are truly orthogonal [2].
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Comprehensive LC remains difficult to achieve since there
is no generic combination of separation mechanisms due to
the analytes and mobile phases properties [3].
From a MS perspective, the co-elution of isobaric
compounds or interferences from the isotopic cluster of
another compound remains a separation challenge. For
decades, ion mobility spectrometry (IMS), which separates
ions according to their size-to-charge ratio and their
interactions with a gas, has been used as a standalone
technique for the detection of chemical warfare agents,
explosives or narcotics [4]. However, IMS is also widely
hyphenated to mass spectrometry (IMS-MS) and is used for
structural studies of small molecules or biopolymers [5]. In
addition, the orthogonality of both techniques has also the
advantage to separate isomeric compounds (e.g., enan-
tiomers [6] and conformers [7, 8]). Kanu et al. [9] recently
reviewed the four methods of performing IMS among
which field-asymmetric waveform ion mobility spectrome-
try (FAIMS), also known as differential ion mobility
spectrometry (DMS), is an alternative to the traditional
drift tube or the traveling-wave devices [10]. Guevremont
reviewed the FAIMS fundamentals and history, as well as
its different applications for small and large molecules [11].
Two different device designs exist and both are continu-
ously able to monitor the ions produced by electrospray,
unlike the drift tube format that injects pulses of ions (e.g.,
Bradbury–Nielsen ion gate). FAIMS devices are mainly
hyphenated to low resolving power MS analyzers like
quadrupoles or linear ion traps. Nowadays, the FAIMS
acronym is commonly associated with the concentric
cylindrical electrodes design, whereas DMS is related to
the parallel planar electrodes device. DMS operates with an
asymmetric electric field applied between the two planar
electrodes perpendicular to the ions motion. The gap is
normally filled with a transport gas at a controlled pressure
and temperature. The ion mobility is different when the
analyte experiences the low-field portion than for the high-
field portion of the oscillating electric field. Thus ions are
drifting towards one of the two electrodes and a specific
compensation voltage (CoV) is required to avoid their
neutralization onto the electrodes. In recent years, the
coupling of DMS to MS analysis has mainly focused on
the elimination of chemical noise [12]. More recently, it has
been demonstrated that the addition of gas-phase modifiers
in the vapor state could significantly improve the separation
power of DMS device [13, 14] and could clearly be
orthogonal to other techniques such as LC.
Here, we discuss the different strategies that can be
chosen for complex samples analysis in order to increase
the resolving power of either MS or LC and enhance the
overall liquid chromatography–mass spectrometry (LC-
MS) assay selectivity. When multidimensional separation
is required, the gas-phase separation dimension provided by
DMS can be easily implemented. Therefore, this paper also
focuses on real-time 2D separation, which can be per-
formed with the first dimension relying on LC and the
second dimension relying on DMS. The data obtained
during the analysis of complex matrix (e.g., urine) and the
benefits of the approach in improving the MS and MS/MS
information obtained on a triple quadrupole linear ion trap
(QqQLIT) are illustrated.
Experimental section
Chemicals and sample preparation
Formic acid (FA) was purchased from Merck (Darmstadt,
Germany). Acetonitrile, methanol (MeOH), isopropanol
(i-PrOH), and ethanol (EtOH) were of HPLC-grade and
purchased from VWR International (Nyon, Switzerland).
Ultrapure water was provided by a Milli-Q Gradient
A10 system (Millipore, Bedford, MA).
The “316 mix” consisted of eight compounds (i.e.,
bromazepam (BRO), chlorprothixene (CHP), clonazepam
(CLO), fendiline (FEN), flusilazol (FLU), oxfendazole
(OXF), oxycodone (OXC), pamaquine (PAM)) possessing a
nominal mass of m/z 316 when using positive electrospray
ionization. All these compounds were part of the low
molecular weight compounds (LMWC)mix defined hereafter.
The “LMWC mix” was made of 36 LMWC purchased
from Sigma-Aldrich (Oakville, ON, Canada), Cerilliant
(Round Rock, TX, USA) or Toronto Research Chemicals
(North York, ON, Canada) (see Table S1 in the Electronic
supplementary material (ESM)).
As a complex sample, human urine was chosen and diluted
2-fold by spiking the LMWC mix at a final concentration of
10 ng/ml.
High-resolution MS infusion experiments
High-resolution MS experiments were carried out on a APEX
III FT-ICR-MS from Bruker Daltonics (Bremen, Germany)
equipped with a 9.4-Tesla/160 mm bore actively screened
superconducting magnet system from Magnex Scientific
(Yarnton, Oxford, UK) and with a cylindrical ICR cell that
has equipotential-line-segmented trapping plates (“infinity
cell”). Infusion of the 316mix (1–40μg/ml in 0.1% FAwater–
MeOH (1:1, v/v)) was done at 5 μl/min with an external
syringe pump. Electrospray voltage was of 4.5 kV, nitrogen
was used as nebulizing gas, capillary exit voltage was set at
80 V and drying gas temperature was of 200 °C. Hexapole
ion accumulation was of 0.4 s and the ions transfer time-of-
flight was set to 1.7 ms. MS spectrum was resulting from
eight accumulated spectra acquired in narrowband detection
centered on m/z 316 with a mass window of 2.36 u. The time
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domain (FID) size was of 32 k data points with a transient
length of 4.771 s. The FID signal was baseline corrected and
Fourier transformed with the power calculation mode to
produce a frequency spectrum finally converted into an m/z
spectrum.
UHPLC-MS experiments
The ultra-high-pressure liquid chromatography (UHPLC)
system was an UltiMate 3000 RSLC system from Dionex
(Germering, Germany). Separation was performed on a
100×2.1-mm i.d. (1.7 μm) Kinetex XB-C18 core-shell
column from Phenomenex (Torrance, CA, USA). Mobile
phase A consisted of 0.1% FA in water:acetonitrile (98:2,v/v)
and mobile phase B was made of 0.1% FA in acetonitrile.
The flowrate was of 300 μl/min with a column oven
temperature of 50 °C. The gradient was linear from 5% to
95% B in 3 min with a washing step of 1 min before column
re-equilibration.
MS experiments were carried out on a TripleTOF 5600
(AB Sciex) equipped with a Turbo-V Duo Ionspray
interface and a calibrant delivery system used for the
time-of-flight calibration. Electrospray voltage was of
5.5 kV, nitrogen was used for nebulizing, curtain and
collision gases. Ion source gases were set at 40 and 50 psi
for GS1 and GS2 respectively. Curtain gas was of 25 psi.
Ionspray source temperature was of 600 °C. Mass range
was monitored from m/z 50 to 1,000 with an accumulation
time of 50 ms to ensure accurate sampling of the LC peaks.
DMS-MS/MS infusion experiments
A differential ion mobility device was mounted on a
QqQLIT mass spectrometer (QTRAP 5500, AB Sciex,
Concord, ON, Canada) [15]. A Turbo-V Ionspray source
was used for positive electrospray ionization (ESI) with a
voltage of 5.5 kV and a temperature of 150 °C. The DMS
separation voltage (SV; i.e. asymmetric rf peak-to-peak
voltage) was ramped from 1.0 to 3.8 kV by steps of 200 V.
The CoV was ramped from −65 to +20 V by steps of 0.2 V
(laboratory frame). DMS resolution was set to low and the
curtain gas (i.e., nitrogen) was of 10 psi. The DMS cell
temperature was of 150 °C. In order to enhance the DMS
separation power, several gas-phase modifiers (i.e., metha-
nol, ethanol, and isopropanol) were added separately to the
curtain gas at a concentration of 1.5% by volume using an
external pumping device. The modifier was allowed to
evaporate completely in the gas before its introduction into
the DMS cell. Infusions of the 316 mix (25–500 ng/ml in
0.1% FA water–MeOH (1:1, v/v)) were done at 7 μl/min
with the MS built-in syringe pump.
Enhanced product ion (EPI) MS/MS experiments were
acquired fromm/z 80 to 350 at a scanning speed of 1,000 u/s
with a fixed trap fill time of 2 ms (Q0 trapping active and Q1
segments duration adjusted). A generic collision energy (CE)
of 45 eV with a CE spread of 15 eV was applied, nitrogen
was used as collision gas, and Q1 analyzer was operated at
unit resolution for the precursor ion selection.
HPLC×DMS-MS experiments
The binary high-pressure gradient LC system was a
Prominence LC-20 AD XR system from Shimadzu (Kyoto,
Japan). Separation was performed on a 50×20-mm i.d.
(5 μm) Hypersil Gold C18 column from Thermo Fisher
Scientific (Waltham, MA, USA). Mobile phase A consisted
of 0.1% FA in water/acetonitrile (98:2, v/v) and mobile
phase B was made of 0.1% FA in acetonitrile. The flowrate
was of 250 μl/min and the gradient was linear from 5% to
99% B in 10 min with a washing step of 2 min before
column re-equilibration.
MS(/MS) experiments were performed with the differential
ion mobility device mounted on the QqQLIT mass spectrom-
eter (QTRAP 5500, AB Sciex). A Turbo-V Ionspray source
was used for positive ESI with a voltage of 4 kV and a
temperature of 650 °C. When the DMS device was turned
on, a continuous SVof 3.5 kV was applied. DMS resolution
was set to low and the curtain gas was of 10 psi. The organic
gas-phase modifier was isopropanol added at 1.5% in the
curtain gas. The CoV was stepped from −32 to +12 V with
steps of 1.2 V (laboratory frame).
Enhanced MS scan was performed from m/z 250 to 500
at a scanning speed of 10,000 u/s with a fixed trap fill time
of 5 ms. Targeted MS/MS experiments for the 316 mix
compounds were acquired in EPI mode from m/z 100 to
320 with collision energy of 35 eV and Q1 operating at unit
resolution.
Software for data acquisition and processing
DMS and MS experiments conducted on the QTRAP 5500
were acquired by a modified Analyst 1.5 software version
(AB Sciex). FT-MS experiments were acquired by apex-
Control 2.0 software (Bruker Daltonics). Data processing
was done by using PeakView 1.1 software (AB Sciex) for
QTRAP data or by using DataAnalysis 3.4 software
(Bruker) for FT-MS data.
Results and discussion
Strategies to separate compounds with identical nominal
mass
A standard mixture of eight low molecular weight
compounds with identical nominal mass has been used to
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illustrate different strategies based on MS that can be
applied for their separation. All these compounds possess
different structures and chemical properties, different exact
masses and are all ionized by positive electrospray (Fig. 1
and Table 1).
Given that these compounds are of identical nominal mass
but are not isobaric, therefore the first MS-based strategy
when instrumentation is available is to use high-resolution
mass spectrometers such as FT-ICR-MS or Orbitrap to
separate the compounds based on their exact mass. In the
standard mixture, the exact masses of the protonated
molecular ions span from m/z 316.007993 (bromazepam) to
m/z 316.238339 (pamaquine) corresponding to a m/z window
of 0.230346 u. Figure 2a represents the MS spectrum
obtained by infusing the 316 mix solution in a FT-ICR-MS
instrument with a resolving power at FWHM of about
1,000,000. All the compounds are baseline resolved with a
mass accuracy of 0.3–0.4 ppm. However, in the case of this
316 mix solution, MS instruments with a resolving power of
ca. 60,000 would have been sufficient to baseline separate
the critical pair of compounds with the smallest mass
difference of 15 mmu (i.e., CHP and FLU).
When high resolving power MS is not accessible or
when analyzing isobaric compounds like structural isomers
[16], a chromatographic or electrophoretic technique
hyphenated to MS is generally used, such as GC- or LC-
MS. The separation of the compounds in this second
strategy mainly is based on their chemical properties, such
as hydrophobicity (e.g., logP and logD) or the existence of
acidic/basic moieties (e.g., pKa) and not based on their
exact mass. As an example, Fig. 2b shows the UHPLC-MS
separation of the “316 mix” obtained with a generic linear
gradient of 3 min performed with a core-shell C18 column.
The compounds are separated according to their increasing
hydrophobicity (Table 1). In this strategy, the addition of a
first chromatographic separation dimension to the MS
resolving power increases the overall peak capacity,
enabling the unequivocal separation of the eight com-
pounds (Fig. 2b (upper panel)). This additional chromato-
graphic dimension renders accessible the use of low and
medium resolving power mass spectrometers, such as
quadrupole-based, (2D/3D)-ion traps or time-of-flight ana-
lyzers. However, it remains important to mention that with
UHPLC separation, LC peak widths are generally of 1–
1.5 s at base which requires a MS duty cycle below 100 ms
to acquire enough data points for an accurate LC peak
definition especially for quantitative analyses [17]. The
lower panel of Fig. 2b shows the eight extracted ion
chromatograms (XIC) with a tolerance window of 20 mmu.
While most of the compounds are baseline resolved, CHP
and FEN are nearly co-eluting since they possess a close
logD value at this mobile phase pH. These two compounds
are, however, resolved in the MS dimension. Nevertheless,
if the same UHPLC separation was performed on a
quadrupole-based MS instrument, these two compounds
would not be separated due to the low MS resolving power
of that type of analyzer.
Another strategy based on MS is to perform MS/MS or
MSn experiments. The fragmentation of LMWC is quite
specific to each analyte and selectivity is increased when
compounds are analyzed based on their collision-induced
fragments. Few years ago, Leuthold et al. [18] already
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mix” compounds
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showed that the use of innovative MS-based workflows
including quantitative SRM and confirmatory MS/MS and
MS3 experiments, were adequate to analyze a pharmaceutical
drug and its metabolite in plasma without chromatographic
step prior to MS detection (i.e., by using a chip-based
electrospray infusion device). In the case of the 316 mix
compounds, all their MS/MS spectra were acquired individ-
ually by infusion on a QqTOF instrument (RP=30,000) with
generic collision energy settings (i.e., CE=45 eV with a
spread of ±15 eV). Figure S1 in the ESM shows that for
nearly all MS/MS spectra, at least one to two intense
fragment ions (labeled in bold with asterisk) can be selected
to build the set of specific SRM transitions for each
compound. However, FEN shares most of its fragment ions
with FLU and an additional chromatographic separation step
or an MS3 experiment would be required to improve the
selectivity of its analysis.
Finally, another strategy based on MS is IMS, which
separates ions according to their size-to-charge ratio and
their interactions with a buffer gas. IMS can be performed
under different principles and in this study FAIMS or DMS
has been used.
Differential ion mobility spectrometry on a QqQLIT MS
instrument
Unlike drift tube IMS where the traveling time of an analyte is
measured and related to its size in space (i.e., collision cross-
section), DMS separation is based on the ion mobility
difference that exists between the high and the low portion
of the oscillating electric field applied between the two planar
electrodes of the DMS cell. Each analyte possess its own
differential mobility and separation occurs by scanning the
compensation voltage applied on one electrode to let ions with
a specific differential mobility value to go through the DMS
cell without being neutralized on the electrodes. Figure 3a
shows the DMS separation obtained for the 316 mix at a
separation voltage of 3,800 V (i.e., field strength in E/N
value of 131 Td). The compounds are barely separated with
CoV values spanning from 2.4 to 7.1 V. This indicates that
the eight analytes with identical nominal mass experience a
relatively similar differential mobility within a narrow 10 V
compensation voltage window.
Nearly a decade ago, Krylova et al. have demonstrated
that moisture in air (above 50 ppm) can change the field
dependence of ion mobility for organophosphorus com-
pounds because their collision cross-section was dictated by
the degree of solvation [19]. Since then, several authors
have demonstrated that the addition of an organic modifier
into the buffer gas can dramatically improve the separation
power of the DMS device [13, 14, 20, 21]. The separation
enhancement has been explained by the formation of
transient clusters between the analyte ions and the neutral
modifier molecules during the low-field portion of the
cycle, which alters the analyte’s mobility because the
collision cross-section of these clusters is larger compared
with the high-field portion where these clusters are broken
up. In this study, three different polar modifiers (i.e.
methanol, ethanol, isopropanol) were added separately into
the curtain gas at a concentration of 1.5% by volume. The
resulting separations of the 316 mix with each modifier are
shown in Fig. 3b–d. For each DMS gas-phase separation,
analyte’s compensation voltages and peak widths at half
height are given in Table 2.
Although the eight compounds possess identical nominal
masses, their chemical properties are quite different
(Table 1) as well as their interactions with the modifiers.
Methanol was found to be the least efficient to enhance the
DMS separation for these compounds (CoV span of
23.4 V). On the contrary, isopropanol provides the largest
CoV separation from −41.3 V for the bromazepam to +1.6 V
for pamaquine. Interestingly, the pamaquine is remaining
within a 10-V window from its initial CoV value (i.e., without
any modifier added in the curtain gas), and is the least affected
by the addition of any of the three polar modifiers,
except for MeOH where its signal is severely suppressed (i.e.,
ca. 100-fold). Schneider et al. [20] have demonstrated that
peak capacity can be used to compare the DMS separation
power for different polar modifiers. Table 2 shows that
the peak capacity increases from 2.7 without gas modifier
Table 1 Chemical properties of
the “316 mix” compoundsa
aCalculated properties with
ACD/Labs software suite release
12.01 (Toronto, Canada)
bpKa values are given for the
most basic moieties
Name Formula MW (g/mol) Exact mass (MH+) LogP LogD (pH 4) pKa
b
Bromazepam C14H10BrN3O 316.2 316.007993 2.3 2.3 2.0
Chlorprothixene C18H18ClNS 315.9 316.092124 5.2 2.1 9.1
Clonazepam C15H10ClN3O3 315.7 316.048345 2.8 2.8 1.6
Fendiline C23H25N 315.5 316.205976 5.2 2.1 9.5
Flusilazol C16H15F2N3Si 315.4 316.107606 3.7 3.6 2.9
Oxfendazole C15H13N3O3S 315.3 316.075038 2.0 1.2 4.5
Oxycodone C18H21NO4 315.4 316.154335 1.6 −1.4 7.6
Pamaquine C19H29N3O 315.5 316.238339 4.4 1.0 10.5
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to 20.4 when using 1.5% isopropanol corresponding to
a 7.5-fold separation enhancement. As a matter of fact, peak
capacity is also depending on the field strength and
comparison between the different modifiers has to be
performed for the same DMS cell conditions (i.e., separation
voltage, molecular density of the gas, and temperature).
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Fig. 3 Separation of the “316 mix” by DMS coupled to a QqQLIT
MS operated in EPI scan mode (E/N=131 Td). DMS separation was
performed: (a) without polar modifier (nitrogen), (b) with 1.5% of
MeOH as modifier, (c) with 1.5% of EtOH as modifier, and (d) with
1.5% of i-PrOH as modifier. Fragment ions monitored in EPI mode
for the extracted CoV traces were: m/z 209.1 (BRO), m/z 231.1
(CHP), m/z 270.1 (CLO), m/z 105.1 (FEN), m/z 165.1 (FLU), m/z 159.0
(OXF), m/z 298.1 (OXY), and m/z 243.2 (PAM)
Table 2 DMS separation of the “316 mix” without or with organic modifiers added into the curtain gas
Compound No modifier (N2) MeOH at 1.5% (v/v) EtOH at 1.5% (v/v) i-PrOH at 1.5% (v/v)
CoV FWHH CoV FWHH CoV FWHH CoV FWHH
Bromazepam 4.5 1.4 −12.9 2.1 −30.0 2.0 −41.3 1.9
Chlorprothixene 7.1 1.8 −6.3 1.7 −12.9 1.8 −15.2 1.8
Clonazepam 3.1 2.0 −15.6 2.0 −24.8 2.0 −31.0 2.0
Fendiline 6.4 2.2 −8.7 1.8 −16.1 2.3 −20.3 2.2
Flusilazol 4.4 1.5 −5.7 1.9 −11.8 2.8 −16.4 2.5
Oxfendazole 2.4 1.3 −18.7 2.2 −29.6 2.5 −34.3 2.2
Oxycodone 5.8 2.1 −13.4 2.2 −27.9 2.0 −34.6 2.0
Pamaquine 6.9 1.7 4.7 2.0 3.8 2.2 1.6 2.2
CoVmin (V) 2.4 −18.7 −30.0 −41.3
CoVmax (V) 7.1 4.7 3.8 1.6
CoVspan (V) 4.7 23.4 33.8 42.9
FWHHaverage (V) 1.8 2.0 2.2 2.1
Peak capacitya 2.7 11.8 15.4 20.4
CoV compensation voltage, EtOH ethanol
a Peak capacity (PC) is calculated according to [20]: PC ¼ CoVmaxCoVminFWHHaverage
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Real-time 2D separation by LC×DMS-MS for the analysis
of a complex sample
As a case study and in order to generate a complex sample, the
eight compounds of the 316 mix were spiked into human
urine together with the other 28 compounds constituting the
“LMWC mix”. The 2-fold diluted spiked urine sample was
then analyzed by LC-MS in Enhanced MS mode with a
generic gradient of 10 min and a 5-cm narrow bore column
packed with a 5-μm C18 stationary phase. Figure 4a shows
the resulting 2D contour plot of the LC-MS analysis where
compounds are mainly separated within the first 8 min and
are spread over the whole m/z range (m/z 250–500).
Contrary to the UHPLC separation shown in Fig. 2b, the
eight compounds are not completely resolved with these LC
conditions (i.e., short column packed with 5 μm particles
and generic 10 min gradient) and some compounds are co-
eluting (cf. contour plot with zoomed region around m/z
316 region in Fig. S2 in the ESM). Moreover, some
isotopic contribution from matrix compounds might inter-
fere (yellow circle showing M+2 isotope of m/z 314.3 in
Fig. S2 in the ESM). Therefore, for a better understanding
and monitoring, the same urine sample was also analyzed in
MS/MS mode (Enhanced Product Ion experiment) targeted
for the 316 mix compounds. Figure 4b shows the TIC
chromatogram of the LC-MS/MS analysis and Fig. 4c
shows the overlaid XIC traces of the eight compounds
based on their specific fragment (as described for Fig. S1 in
the ESM). From the overlaid XIC traces it is obvious that
the peaks 1 and 2 eluting at 4.47 and 5.56 min in the TIC
are constituted of two co-eluting compounds that cannot be
distinguished in the LC-MS contour plot. As a matter of
fact, without the MS/MS dimension artificially added for
this case study, one would have missed this type of
information since their peak shape does not indicate an
underlying second compound at the first glance.
As previously described, the resolving power of the
linear ion trap analyzer is not sufficient to differentiate
these co-eluting compounds and an additional separation
dimension is required. Therefore the DMS cell was
mounted in front of the MS instrument to perform a real-
time gas-phase separation prior MS dimension. In line with
the previous results from Fig. 3, the DMS cell was operated
with the addition of modifier in the curtain gas to enhance
its separation power. However when hyphenated with LC,
the compensation voltage had to be stepped by 1.2 V in order to
scan the CoV domain in 4 s to sample ca. 4–5-fold the LC
peaks (peak widths at the base of 15–20 s). As expected, the
addition of the DMS device in the LC-MS(/MS) analysis
could distinguish the co-eluting compounds without ambiguity.
This is demonstrated in Fig. 5a that shows the composite MS/
MS spectrum of peak 1 without operating the DMS device and
in Fig. 5b, c that shows MS/MS spectra taken at the apex CoV
values corresponding to bromazepam and pamaquine respec-
tively. Similarly, MS/MS spectra from peak 2 with and without
DMS separation are given in Fig. S3 in the ESM.
It is noticeable that the new dimension added to the LC-
MS technique by the DMS gas-phase separation enables to
clearly identify the two co-eluting compounds from peaks 1
and 2 by their distinct MS/MS spectrum. The real-time
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Fig. 4 LC-MS(/MS) separation of the diluted human urine spiked
with the “LMWC mix”. (a) Contour plot of the LC-MS separation
(EMS mode), the intensity threshold (red color) was set at 1e7 cps; (b)
LC-MS/MS separation of the spiked urine targeted for the “316 mix”
compounds (EPI mode—TIC); (c) XIC traces from the EPI experi-
ment based on specific fragments for each compound of the
“316 mix”, the fragment ions used for the extracted traces were the
same as in Fig. 3
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LC×DMS-MS combination expands the peak capacity of
the separation without increasing the LC runtime. However,
the CoV range screening is relatively slow due to the
experiment performed on the QqQLIT instrument and the
CoV domain has to be stepped in order to maintain a
sufficient sampling rate of the LC dimension. Therefore, this
type of coupling would benefit from a faster MS instrument
like the new QqTOF mass spectrometers described previ-
ously (e.g., TripleTOF 5600) with duty cycles as low as 10–
20 ms for acquiring the full MS domain at high resolution.
Such an analytical platform would be of great help in the
case of complex samples analysis.
Conclusions
When analyzing biological fluid extracts by LC-MS, a
higher peak capacity may be required and the use of either
comprehensive LC×LC or high-resolution mass spectrom-
etry such as FT-MS analyzers can fulfill these requirements.
However, these techniques do not have a large users base.
In addition, for some compounds (e.g., isobaric com-
pounds), an additional separation dimension is required.
Differential ion mobility has shown good peak capacity
when a polar modifier is vaporized into the buffer gas (e.g.,
isopropanol). This gas-phase technique separates ions based
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mode) of peak eluting at
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on their size-to-charge ratio and is orthogonal to MS. DMS
allows the continuous monitoring of ions produced by
electrospray and can be easily hyphenated to LC to perform
a real-time 2D separation prior to MS detection. Although the
DMS peak capacity and scanning speed are reduced compared
to LC, a striking point of 2D LC×DMS-MS(/MS) is its ability
to resolve composite MS/MS spectra due to different CoV
values for co-eluting compounds. This is particularly
interesting for metabolomics analyses by LC-MS(/MS)
where structural identification of potential biomarkers is
performed by MS/MS spectra database search. Finally,
when considering the short residence time of ions
through the DMS cell in the present configuration [15],
a fast acquiring MS instruments such as time-of-flight
analyzers would be ideally suited for the LC×DMS
hyphenation and would allow to fully exploit this orthogonal
coupling in qualitative applications.
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